LLR APC Annual Report 2023 -2024(481 KB) - LMSG/LLR APC annual report
Date added: 04th April 2024
Date added: 5th Apr 2024
Drug Name | Classification | Clinical Indication | Comments |
---|---|---|---|
BELUMOSUDIL (Rezurock®) (NEW) | Red | For treating chronic graft-versus host disease after 2 or more systemic treatments in people 12 years and over. | |
BUDESONIDE/ FORMOTEROL FUMARATE DIHYDRATE INHALER (GoResp Digihaler®) (UPDATED) | Red | Asthma & COPD |
Restricted to severe asthma clinic only on a named patient basis |
FLUOCINOLONE ACETONIDE (Iluvien®) intravitreal implant | Red | Diabetic macular oedema |
In line with NICE TA953 |
HYBRID CLOSED LOOP (NEW) | Red | Diabetes Glucose Monitoring & Delivery System |
In line with NICE TA943 |
INFLIXIMAB | Red | All indications |
As indicated on the LLR Medicines Formulary |
MODAFINIL (UPDATED) | Yellow | Daytime sleepiness associated with Narcolepsy and existing patients being treated for Daytime Sleepiness associated with Obstructive Sleep Apnoea Syndrome & Idiopathic Hypersomnia. | |
NEFOPAM (NEW) | Red | For post-operative analgesia for patients undergoing THR / THK |
ONLY for patients who are intolerant of NSAIDs, tramadol and/or opioids. 5 – 7 days treatment only. |
PARECOXIB (NEW) | Red | Single intra-operative dose for the management of acute postoperative pain. |
Only to be given to patients for whom PR diclofenac is not appropriate. |
SOLRIAMFETOL (Sunosi ®) (UPDATED) | Yellow | For treating excessive daytime sleepiness caused by narcolepsy |
In line with NICE TA758 |
TARGETED-RELEASE BUDESONIDE (NEW) | Red | for treating primary IgA nephropathy |
In line with NICE TA937 |
Recent documents from LLR APC and TAS
Date added: 04th April 2024
Date added: 5th Apr 2024
Date added: 4th Apr 2024
Date added: 4th Apr 2024
Date added: 28th Mar 2024
Date added: 28th Mar 2024
Date added: 27th Mar 2024
Version 1 Uploaded March 2024
Date added: 25th Mar 2024
Version 1 Uploaded March 2024
Date added: 25th Mar 2024
Version 1 Uploaded March 2024
Date added: 20th Mar 2024
Version 1 Uploaded March 2024
Date added: 20th Mar 2024
Version 1 Uploaded March 2024
Date added: 20th Mar 2024
Version 3.0 Uploaded March 2024
Date added: 12th Oct 2020
Version 1.8 Uploaded April 2024
Date added: 21st May 2019
Version 23 Uploaded April 2024
Date added: 2nd May 2019
Version 1.7 Uploaded April 2024
Date added: 9th Aug 2018
Updated April 2024
Date added: 19th Apr 2017
Version 1 Updated April 2024
Date added: 11th Aug 2016
Version 2.0 Uploaded April 2024
Date added: 9th Dec 2015
Version 4.0 Uploaded April 2024
Date added: 21st Sep 2015
In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.
Leicestershire Health Community comprises the Leicester, Leicestershire and Rutland Integrated Care Board, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more